UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016874 |
|---|---|
| Receipt number | R000019585 |
| Scientific Title | Phase1/2study evaluating safety and efficacy of bortezomib-lenalidomid-dexamethasone induction therapy followed by lenalidomide-dexamethasone consolidation and lenalidomide maintenance for newly diagnosed patients with multiple myeloma eligible for stem cell transplantation. |
| Date of disclosure of the study information | 2015/03/23 |
| Last modified on | 2018/06/01 15:23:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/03/23 02:23:18 | ||
| 2 | Update | 2015/03/23 13:26:11 | Email1 |
|
| 3 | Update | 2015/10/23 16:27:58 | Recruitment status |
|
| 4 | Update | 2018/06/01 15:23:30 | Name of primary person or sponsor Organization |
